1. Home
  2. AIR vs RCUS Comparison

AIR vs RCUS Comparison

Compare AIR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AAR Corp.

AIR

AAR Corp.

HOLD

Current Price

$97.22

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$17.77

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIR
RCUS
Founded
1951
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.2B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
AIR
RCUS
Price
$97.22
$17.77
Analyst Decision
Buy
Strong Buy
Analyst Count
7
15
Target Price
★ $154.50
$41.00
AVG Volume (30 Days)
601.8K
★ 2.0M
Earning Date
09-28-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1288.57
N/A
EPS
★ 1.00
N/A
Revenue
N/A
★ $247,000,000.00
Revenue This Year
$11.56
N/A
Revenue Next Year
$6.80
N/A
P/E Ratio
$95.65
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$76.10
$17.43
52 Week High
$154.00
$31.74

Technical Indicators

Market Signals
Indicator
AIR
RCUS
Relative Strength Index (RSI) 33.88 25.73
Support Level N/A N/A
Resistance Level $121.24 $24.38
Average True Range (ATR) 3.40 1.67
MACD 0.65 -0.48
Stochastic Oscillator 51.67 3.77

Price Performance

Historical Comparison
AIR
RCUS

About AIR AAR Corp.

AAR Corp offers a broad line of products and services to commercial and government aerospace customers and operates internationally. It is a diversified provider of services and products to the commercial aviation and government and defense markets, serving aircraft fleet operators, original equipment manufacturers, independent service providers, and domestic and foreign military customers. It operates through the Parts Supply, Repair, Engineering and Software, Government Solutions, and Legacy Commercial Programs segments. The Parts Supply segment mainly consists of new parts distribution and sales of used serviceable material, including aircraft, engine, and airframe parts and components (USM), and generates the maximum revenue. It generates the maximum revenue from North America.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: